CP-526,555

· Pfizer

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CP-526,555, covering 2007-06-04 to 2015-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation [Phase 2]